Patent details

EP3342411 Title: RAPAMYCIN DERIVATIVE FOR TREATING PANCREAS CANCER

Basic Information

Publication number:
EP3342411
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP181557240
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RAPAMYCIN DERIVATIVE FOR TREATING PANCREAS CANCER
French Title of Invention:
DÉRIVÉ DE RAPAMYCINE POUR LE TRAITEMENT DU CANCER DU PANCRÉAS
German Title of Invention:
RAPAMYCIN-DERIVAT ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS
SPC Number:
LUC00148

Dates

Filing date:
18/02/2002
Grant date:
21/08/2019
EP Publication Date:
04/07/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/08/2019
EP B1 Publication Date:
21/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2020
 
 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:
10/06/2020
To:
31/07/2020

Name:
NOVARTIS PHARMA AG
Address:
Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

From:
14/08/2019
To:
10/06/2020

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
O`Reilly, Terence
Address:
Switzerland (CH)

2

Name:
Lane, Heidi
Address:
Switzerland (CH)

3

Name:
Wood, Jeanette Marjorie
Address:
Switzerland (CH)

Priority

1

Priority Number:
0104072
Priority Date:
19/02/2001
Priority Country:
United Kingdom (GB)

2

Priority Number:
0124957
Priority Date:
17/10/2001
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/436; A61P 35/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2020/08
Publication date:
13/07/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201934
Publication date:
21/08/2019
Description:
Grant (B1)

2

Issue number:
202026
Publication date:
24/06/2020
Description:
Opposition procedure started

3

Issue number:
202025
Publication date:
17/06/2020
Description:
Opposition procedure started

4

Issue number:
202024
Publication date:
10/06/2020
Description:
Opposition procedure started

5

Issue number:
202023
Publication date:
03/06/2020
Description:
Opposition procedure started

6

Issue number:
202013
Publication date:
25/03/2020
Description:
Opposition procedure started

7

Issue number:
201945
Publication date:
06/11/2019
Description:
Opposition procedure started

8

Issue number:
201940
Publication date:
02/10/2019
Description:
Opposition procedure started

9

Issue number:
202404
Publication date:
24/01/2024
Description:
Opposition rejected; Patent maintained as granted

10

Issue number:
202036
Publication date:
02/09/2020
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000167A
Date Registered:
10/06/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NOVARTIS PHARMA AG
Address:
Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/02/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
10/06/2020 Request For Change 12
15/06/2020 Outgoing Correspondence 2